skip to main content

Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF-BNLI Criteria

Illidger TM, Mayes S, Pettengell R, Bates AT, Bayne M, Radford JA, Ryder WD, Le Gouill S, Jardin F, Tipping J, Zivanovic M, Kraeber-Bodere F, Bardies M, Bodet-Milin C, Malek E, Huglo D, Morschhauser F 2014

Full text available

Citations Cited by

Searching Remote Databases, Please Wait